These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29679315)

  • 1. Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.
    Mulhern B; Feng Y; Shah K; Janssen MF; Herdman M; van Hout B; Devlin N
    Pharmacoeconomics; 2018 Jun; 36(6):727. PubMed ID: 29679315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: 3L, 5L, What the L? A NICE Conundrum.
    Devlin N; Brazier J; Simon Pickard A; Stolk E
    Pharmacoeconomics; 2018 Jun; 36(6):729. PubMed ID: 29744795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
    Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
    Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.
    Janssen MF; Bonsel GJ; Luo N
    Pharmacoeconomics; 2018 Jun; 36(6):675-697. PubMed ID: 29470821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.
    Khan I; Morris S; Pashayan N; Matata B; Bashir Z; Maguirre J
    Health Qual Life Outcomes; 2016 Apr; 14():60. PubMed ID: 27072351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.
    Wang P; Luo N; Tai ES; Thumboo J
    Value Health Reg Issues; 2016 May; 9():57-62. PubMed ID: 27881260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups.
    Feng Y; Devlin N; Bateman A; Zamora B; Parkin D
    Value Health; 2019 Mar; 22(3):355-361. PubMed ID: 30832974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
    Selivanova A; Buskens E; Krabbe PFM
    Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.
    Pickard AS; Kohlmann T; Janssen MF; Bonsel G; Rosenbloom S; Cella D
    Med Care; 2007 Sep; 45(9):812-9. PubMed ID: 17712251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of the EQ-5D-3L and EQ-5D-5L in patients following total hip or knee replacement.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Johnson JA
    Qual Life Res; 2019 Sep; 28(9):2409-2417. PubMed ID: 31089988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
    Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
    Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
    Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.